Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
The Most Important Crossroads in Olympic History - 2Palestine weekly wrap: Protests sweep West Bank after death penalty law
- 3Kids get diseases like lupus, too. As researchers hunt better treatments, this camp brings joy
- 4Churches and politicians in South Sudan call for 'lasting peace' in Easter messages
- 5A decade after Brazil’s deadly dam collapse, Indigenous peoples demand justice on the eve of COP30
- IDF strikes Tehran command centers, weapon production sites
- Nature: 10 High priority Setting up camp Spots In Europe
- Knesset FADC extends emergency draft for 280,000 IDF reservists until January 1
- NASA's make-or-break moon shot
- Find Exemplary Scents: An Extensive Aide
- Thousands of ultra-orthodox protest in Jerusalem against conscription
- Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
- The most effective method to Augment Benefits in Gold Speculation: Systems and Tips
- Figure out how to Detect the Best Rooftop Substitution Choices
